Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biological and Biochemical Products	745.31M	884.93M	974.51M	943.40M	612.17M
Biological and Biochemical Products Growth	-15.78%	-9.19%	3.30%	54.11%	36.39%
Total	745.31M	884.93M	974.51M	943.40M	612.17M
Total Growth	-15.78%	-9.19%	3.30%	54.11%	36.39%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
East China	266.98M	397.89M	480.04M	451.81M	341.59M
East China Growth	-32.90%	-17.11%	6.25%	32.27%	49.34%
North China	221.03M	118.01M	170.14M	174.05M	100.00M
North China Growth	87.31%	-30.64%	-2.24%	74.04%	32.47%
Central China	25.68M	61.37M	44.64M	56.76M	73.42M
Central China Growth	-58.16%	37.50%	-21.37%	-22.68%	28.71%
Southern China	51.31M	60.49M	75.37M	69.76M	49.87M
Southern China Growth	-15.17%	-19.74%	8.03%	39.89%	-3.76%
South-West China	66.44M	77.64M	87.08M	85.27M	25.05M
South-West China Growth	-14.43%	-10.84%	2.12%	240.43%	-
Northwestern China	48.80M	49.53M	39.35M	36.83M	11.73M
Northwestern China Growth	-1.48%	25.85%	6.85%	214.05%	-
Northeast China	32.79M	35.45M	37.16M	44.60M	9.68M
Northeast China Growth	-7.50%	-4.60%	-16.67%	360.54%	7.76%
Overseas	32.27M	84.56M	40.73M	24.31M	816.51K
Overseas Growth	-61.83%	107.59%	67.54%	2877.51%	-
Total	745.31M	884.93M	974.51M	943.40M	612.17M
Total Growth	-15.78%	-9.19%	3.30%	54.11%	36.39%

Source: S&P Global Market Intelligence.